Effects of SARS-CoV-2 Main Protease Mutations at Positions L50, E166, and L167 Rendering Resistance to Covalent and Noncovalent Inhibitors
Journal of Medicinal Chemistry · 24.10.2024 · 67 (20) · 18478-18490
DOI: 10.1021/acs.jmedchem.4c01781 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 07.10.2024. Verfasst von Andrey Kovalevsky und 8 weiteren Autor:innen. Beteiligte Einrichtung: Neutron Scattering Division, Oak Ridge National Laboratory, 1 Bethel Valley Road, Oak Ridge, Tennessee 37831, United States. Hauptthemen laut MEDLINE: SARS-CoV-2, Coronavirus 3C Proteases, Mutation, Drug Resistance, Viral. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Intramural NIH HHS, U.S. Department of Health and Human Services.
Abstract (Originalsprache)
SARS-CoV-2 propagation under nirmatrelvir and ensitrelvir pressure selects for main protease (MPro) drug-resistant mutations E166V (DRM2), L50F/E166V (DRM3), E166A/L167F (DRM4), and L50F/E166A/L167F (DRM5). DRM2-DRM5 undergoes N-terminal autoprocessing to produce mature MPro with dimer dissociation constants (Kdimer) 2-3 times larger than that of the wildtype. Co-selection of L50F restores catalytic activity of DRM2 and DRM4 from ∼10 to 30%, relative to that of the wild-type enzyme, without altering Kdimer. Binding affinities and thermodynamic profiles that parallel the drug selection pressure, exhibiting significant decreases in affinity through entropy/enthalpy compensation, were compared with GC373. Reorganization of the active sites due to mutations observed in the inhibitor-free DRM3 and DRM4 structures as compared to MProWT may account for the reduced binding affinities, although DRM2 and DRM3 complexes with ensitrelvir are almost identical to MProWT-ensitrelvir. Chemical reactivity changes of the mutant active sites due to differences in electrostatic and protein dynamics effects likely contribute to losses in binding affinities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Neutron Scattering Division, Oak Ridge National Laboratory, 1 Bethel Valley Road, Oak Ridge, Tennessee 37831, United States.
- Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, DHHS, Bethesda, Maryland 20892-0520, United States.
- Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, DHHS, Bethesda, Maryland 20892-0540, United States.
- Second Target Station, Oak Ridge National Laboratory, 1 Bethel Valley Road, Oak Ridge, Tennessee 37831, United States.
- Department of Natural Sciences, Tennessee Wesleyan University, Athens, Tennessee 37303, United States.
ORCID-Profile: Andrey Kovalevsky, Rodolfo Ghirlando, Leighton Coates, John M Louis
Förderung
- Intramural NIH HHS
- U.S. Department of Health and Human Services
Zitieren
APA
Kovalevsky, A., Aniana, A., Ghirlando, R., Coates, L., Drago, V. N., Wear, L., Gerlits, O., Nashed, N. T., & Louis, J. M. (2024). Effects of SARS-CoV-2 Main Protease Mutations at Positions L50, E166, and L167 Rendering Resistance to Covalent and Noncovalent Inhibitors. Journal of Medicinal Chemistry, 67(20), 18478-18490. https://doi.org/10.1021/acs.jmedchem.4c01781
Vancouver
Kovalevsky A, Aniana A, Ghirlando R, Coates L, Drago VN, Wear L, et al. Effects of SARS-CoV-2 Main Protease Mutations at Positions L50, E166, and L167 Rendering Resistance to Covalent and Noncovalent Inhibitors. Journal of Medicinal Chemistry. 2024;67(20):18478-18490. doi:10.1021/acs.jmedchem.4c01781
BibTeX
@article{Kovalevsky2024,
author = {Kovalevsky, Andrey and Aniana, Annie and Ghirlando, Rodolfo and Coates, Leighton and Drago, Victoria N and Wear, Lauren and Gerlits, Oksana and Nashed, Nashaat T and Louis, John M},
title = {Effects of SARS-CoV-2 Main Protease Mutations at Positions L50, E166, and L167 Rendering Resistance to Covalent and Noncovalent Inhibitors},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {20},
pages = {18478--18490},
doi = {10.1021/acs.jmedchem.4c01781}
}
EUVIMED